Cleared Traditional

ARTSMedia Oocyte Aspiration Medium (502020, 502050, 502100) (K241132) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241132 · Artsmedia Denmark Aps · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
238d
Days
Class 2
Risk

K241132 is an FDA 510(k) clearance for the ARTSMedia Oocyte Aspiration Medium (502020, 502050, 502100). Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Artsmedia Denmark Aps (Virum, DK). The FDA issued a Cleared decision on December 18, 2024 after a review of 238 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Artsmedia Denmark Aps devices

Submission Details

510(k) Number K241132 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2024
Decision Date December 18, 2024
Days to Decision 238 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 160d · This submission: 238d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 50
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K241132.
CaseMONO™ Culture (CMON)
K242107 · Casebioscience, Inc. · Mar 2025
Sperm Freezing Medium
K242043 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jan 2025
ARTSMedia Semen Wash Medium
K241095 · Artsmedia Denmark Aps · Dec 2024
Giftlife® Single-Step Medium Plus
K242968 · Gimbo Medical Technology Shenzhen Co., Ltd. · Nov 2024
V-VITFREEZE and V-VITWARM
K240176 · Vitromed GmbH · Sep 2024
Vitrification Solution Set and Warming Solution Set
K233846 · Ecmpc, LLC · Aug 2024